LGT Financial Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-165
| Closed | -$22.5K | – | 583 |
|
|
2024
Q4 | $22.5K | Hold |
165
| – | – | 0.05% | 289 |
|
|
2024
Q3 | $19K | Hold |
165
| – | – | 0.05% | 294 |
|
|
2024
Q2 | $22.7K | Hold |
165
| – | – | 0.05% | 277 |
|
|
2024
Q1 | $22.8K | Hold |
165
| – | – | 0.03% | 340 |
|
|
2023
Q4 | $21.7K | Sell |
165
-8
| -5% | -$1.05K | 0.03% | 334 |
|
|
2023
Q3 | $19.5K | Buy |
+173
| New | +$19.5K | 0.02% | 348 |
|